199 related articles for article (PubMed ID: 38659056)
21. Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types.
Li Y; Sundquist K; Zhang N; Wang X; Sundquist J; Memon AA
EBioMedicine; 2023 Feb; 88():104432. PubMed ID: 36634566
[TBL] [Abstract][Full Text] [Related]
22. Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization.
Zhang C; He Y; Liu L
J Headache Pain; 2024 Jun; 25(1):100. PubMed ID: 38867170
[TBL] [Abstract][Full Text] [Related]
23. Mendelian randomization analyses of known and suspected risk factors and biomarkers for myasthenia gravis overall and by subtypes.
Wang W; Ge W; Feng J; Huang M; Zhang X; Xia J; Wang L; Li C
BMC Neurol; 2024 Jan; 24(1):33. PubMed ID: 38238684
[TBL] [Abstract][Full Text] [Related]
24. Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes.
Liu Z; Peng Z; Lin H; Zhou K; Liang L; Cao J; Huang Z; Mei J
Respir Res; 2024 May; 25(1):217. PubMed ID: 38783236
[TBL] [Abstract][Full Text] [Related]
25. Novel Drug Targets for Atrial Fibrillation Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Ning Z; Huang Y; Lu H; Zhou Y; Tu T; Ouyang F; Liu Y; Liu Q
Cardiovasc Drugs Ther; 2023 May; ():. PubMed ID: 37212950
[TBL] [Abstract][Full Text] [Related]
26. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer.
Song W; Li Y; Yao Y; Sun S; Guan X; Wang B
BMC Cancer; 2024 Jun; 24(1):680. PubMed ID: 38834983
[TBL] [Abstract][Full Text] [Related]
27. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
28. Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia.
Yin KF; Chen T; Gu XJ; Su WM; Jiang Z; Lu SJ; Cao B; Chi LY; Gao X; Chen YP
J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38644354
[TBL] [Abstract][Full Text] [Related]
29. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
[TBL] [Abstract][Full Text] [Related]
30. Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.
Li H; Li W; Li D; Yuan L; Xu Y; Su P; Wu L; Zhang Z
Front Endocrinol (Lausanne); 2024; 15():1366290. PubMed ID: 38915894
[TBL] [Abstract][Full Text] [Related]
31. Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.
Baird DA; Liu JZ; Zheng J; Sieberts SK; Perumal T; Elsworth B; Richardson TG; Chen CY; Carrasquillo MM; Allen M; Reddy JS; De Jager PL; Ertekin-Taner N; Mangravite LM; Logsdon B; Estrada K; Haycock PC; Hemani G; Runz H; Smith GD; Gaunt TR;
PLoS Genet; 2021 Jan; 17(1):e1009224. PubMed ID: 33417599
[TBL] [Abstract][Full Text] [Related]
32. Integrated mendelian randomization analyses highlight AFF3 as a novel eQTL-mediated susceptibility gene in renal cancer and its potential mechanisms.
Wang Q; Chen S; Wang G; Zhang T; Gao Y
BMC Cancer; 2024 Jun; 24(1):739. PubMed ID: 38886730
[TBL] [Abstract][Full Text] [Related]
33. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.
Zhou S; Tao B; Guo Y; Gu J; Li H; Zou C; Tang S; Jiang S; Fu D; Li J
J Transl Med; 2024 Jun; 22(1):557. PubMed ID: 38858729
[TBL] [Abstract][Full Text] [Related]
34. Enhancer promoter interactome and Mendelian randomization identify network of druggable vascular genes in coronary artery disease.
Chignon A; Mathieu S; Rufiange A; Argaud D; Voisine P; Bossé Y; Arsenault BJ; Thériault S; Mathieu P
Hum Genomics; 2022 Mar; 16(1):8. PubMed ID: 35246263
[TBL] [Abstract][Full Text] [Related]
35. Mendelian Randomization Study Using Dopaminergic Neuron-Specific eQTL Nominates Potential Causal Genes for Parkinson's Disease.
Dang X; Zhang Z; Luo XJ
Mov Disord; 2022 Dec; 37(12):2451-2456. PubMed ID: 36177513
[TBL] [Abstract][Full Text] [Related]
36. Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease.
Su WM; Gu XJ; Dou M; Duan QQ; Jiang Z; Yin KF; Cai WC; Cao B; Wang Y; Chen YP
J Neurol Neurosurg Psychiatry; 2023 Nov; 94(11):954-961. PubMed ID: 37349091
[TBL] [Abstract][Full Text] [Related]
37. Association between COVID-19 and myasthenia gravis (MG): A genetic correlation and Mendelian randomization study.
Sun D; Tu L; Wang X; Du Q; Wang R; Shi Z; Chen H; Zhou H
Brain Behav; 2023 Nov; 13(11):e3239. PubMed ID: 37638499
[TBL] [Abstract][Full Text] [Related]
38. Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.
Zheng J; Zhang Y; Zhao H; Liu Y; Baird D; Karim MA; Ghoussaini M; Schwartzentruber J; Dunham I; Elsworth B; Roberts K; Compton H; Miller-Molloy F; Liu X; Wang L; Zhang H; Smith GD; Gaunt TR
EBioMedicine; 2022 Jul; 81():104112. PubMed ID: 35772218
[TBL] [Abstract][Full Text] [Related]
39. Myasthenia gravis and five autoimmune diseases: a bidirectional Mendelian randomization study.
Li K; Ouyang Y; Yang H
Neurol Sci; 2024 Apr; 45(4):1699-1706. PubMed ID: 37910321
[TBL] [Abstract][Full Text] [Related]
40. Platelet Glycoprotein Ib α-Chain as a Putative Therapeutic Target for Juvenile Idiopathic Arthritis: A Mendelian Randomization Study.
Luo S; Clarke SLN; Ramanan AV; Thompson SD; Langefeld CD; Marion MC; Grom AA; Schooling CM; Gaunt TR; Yeung SLA; Zheng J
Arthritis Rheumatol; 2021 Apr; 73(4):693-701. PubMed ID: 33079445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
